Jonathan David Schwartz Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jonathan David Schwartz.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jonathan David Schwartz. Jonathan David Schwartz is a Chief Medical Officer in ROCKET PHARMACEUTICALS, INC. ($RCKT).

Address: C/O ROCKET PHARMACEUTICALS, INC. 430 EAST 29TH STREET, SUITE 1040 NEW YORK 10016 NY

Companies in which Jonathan David Schwartz is an Insider

ROCKET PHARMACEUTICALS, INC.

Trading Symbol: RCKT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jonathan David Schwartz: Chief Medical Officer
Holdings: 11,428 shares
Current Value: $19,428
Latest Transaction: Feb 08 2021
$RCKT Market Capitalization: $44.43M
$RCKT Previous Close: $1.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Jonathan David Schwartz

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 08 2021RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...Option ExerciseD62.3235,0002,181,20035,000
Feb 03 2021RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...Option ExerciseD1.21213,101257,85238,309
Feb 03 2021RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...Option ExerciseD1.6911,42819,3130
Feb 03 2021RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...BuyM1.21213,101257,852224,52911.4 K to 224.5 K (+1,864.73 %)
Feb 03 2021RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...BuyM1.6911,42819,31311,4280 to 11.4 K
Feb 10 2020RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...Option ExerciseA23.897,000167,2307,000
Feb 10 2020RCKTROCKET PHARMACEUTI ...Schwartz Jonathan DavidChief Medical Offic ...Option ExerciseA22.7275,0001,704,00075,000

View all Jonathan David Schwartz insider transactions.